|

Human papillomavirus 9-valent vaccine, recombinant Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: 9-valent Gardasil, Gardasil 9, Gardasil-9, Nonavalent HPV vaccine

Pipeline

Phase 2: 1Phase 4: 1Phase 2/3: 1

Top Sponsors

  • Western Institute for Veterans Research1
  • Louisiana State University Health Sciences Center in New Orleans1
  • Centre Oscar Lambret1

Indications

  • Cancer3
  • Cervical Lesion1
  • Oral Cavity Infection1
  • Anal Intraepithelial Neoplasia1
  • Serology1

Other1 trial

Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions
Phase 2

New Orleans, Louisiana1 trial

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

University Medical Center New Orleans

Phase 4

Salt Lake City, Utah1 trial

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

University of Utah Midvalley Health Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.